Aziz Zaanan Selected Research

Epidermal Growth Factor (EGF)

1/2019

Exploring the best treatment options for BRAF-mutant metastatic colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aziz Zaanan Research Topics

Disease

40	Neoplasms (Cancer) 11/2023 - 01/2008
23	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 09/2013
20	Adenocarcinoma 05/2024 - 04/2011
16	Microsatellite Instability 12/2023 - 01/2008
15	Stomach Neoplasms (Stomach Cancer) 01/2023 - 06/2013
12	Colonic Neoplasms (Colon Cancer) 01/2021 - 12/2011
8	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2009
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2014 - 05/2011
3	Dihydropyrimidine Dehydrogenase Deficiency 05/2024 - 01/2020
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020 - 07/2015
2	Disease Progression 04/2024 - 03/2020
2	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 01/2013
2	Residual Neoplasm 09/2021 - 07/2020
2	Chromosomal Instability (Chromosome Stability) 12/2015 - 07/2015
2	Carcinoma (Carcinomatosis) 09/2015 - 04/2015
1	Adenosquamous Carcinoma 01/2023
1	Cholangiocarcinoma 09/2022
1	Frailty 09/2022
1	Crohn Disease (Crohn's Disease) 02/2022
1	Peritoneal Neoplasms 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2021
1	Turcot syndrome 04/2020
1	Genomic Instability 06/2019
1	Adenoma (Adenomas) 01/2018
1	Polyps 01/2018

Drug/Important Bio-Agent (IBA)

19	Fluorouracil (Carac)FDA LinkGeneric 05/2024 - 04/2011
15	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2024 - 12/2011
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2011
8	Immune Checkpoint InhibitorsIBA 04/2024 - 02/2019
8	Trastuzumab (Herceptin)FDA Link 11/2023 - 04/2015
8	Circulating Tumor DNAIBA 09/2021 - 01/2016
7	PlatinumIBA 04/2024 - 04/2011
7	Leucovorin (Folinic Acid)FDA Link 04/2024 - 04/2011
7	Gemcitabine FDA Link 09/2015 - 05/2011
5	Irinotecan (Camptosar)FDA LinkGeneric 04/2024 - 04/2011
4	NivolumabIBA 05/2024 - 04/2020
4	Calcibiotic Root Canal SealerIBA 04/2022 - 07/2015
4	Cetuximab (Erbitux)FDA Link 01/2022 - 05/2016
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2015
3	trifluridine tipiracil drug combinationIBA 05/2024 - 01/2022
3	SaltsIBA 11/2023 - 04/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2014
3	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2018
3	Docetaxel (Taxotere)FDA Link 06/2020 - 04/2014
2	durvalumabIBA 04/2024 - 01/2021
2	tremelimumabIBA 04/2024 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2020
2	ClaudinsIBA 12/2023 - 11/2023
2	Monoclonal AntibodiesIBA 11/2023 - 03/2020
2	taxaneIBA 11/2023 - 01/2021
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 03/2023 - 01/2020
2	Capecitabine (Xeloda)FDA Link 01/2023 - 10/2020
2	pembrolizumabIBA 10/2022 - 01/2022
2	Sorafenib (BAY 43-9006)FDA Link 09/2022 - 01/2013
2	encorafenibIBA 01/2022 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2021
2	Bevacizumab (Avastin)FDA Link 10/2020 - 01/2019
1	zolbetuximabIBA 11/2023
1	RamucirumabIBA 11/2023
1	trastuzumab deruxtecanIBA 07/2023
1	UracilIBA 03/2023
1	XELOXIBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 11/2022
1	Tyrosine Kinase InhibitorsIBA 09/2022
1	sintilimabIBA 01/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2021
1	Carcinoembryonic AntigenIBA 10/2020
1	Insulin (Novolin)FDA Link 04/2020
1	IpilimumabIBA 04/2020
1	LigandsIBA 04/2020
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 04/2020
1	human ERBB2 proteinIBA 03/2020
1	Capsules (Microcapsules)IBA 01/2020
1	Mismatch Repair Endonuclease PMS2IBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	AfatinibIBA 11/2018
1	Lapatinib (GW572016)FDA Link 11/2018
1	prednylidene (Pred)IBA 01/2018
1	Epirubicin (Ellence)FDA LinkGeneric 12/2016
1	Neuropeptide YIBA 01/2016
1	GTP Phosphohydrolases (GTPases)IBA 09/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2015
1	GDC-0623IBA 09/2015

Therapy/Procedure

39	Drug Therapy (Chemotherapy) 04/2024 - 01/2009
12	Adjuvant Chemotherapy 01/2023 - 12/2011
9	Therapeutics 01/2023 - 05/2011
7	Immunotherapy 10/2022 - 01/2019
3	Precision Medicine 11/2022 - 10/2018
2	Neoadjuvant Therapy 04/2020 - 09/2015
1	Combined Modality Therapy 12/2023
1	Radiotherapy 06/2022
1	Induction Chemotherapy 10/2020
1	Chemoradiotherapy 08/2018
1	Folfox protocol 12/2016
1	Ovariectomy (Oophorectomy) 04/2016